Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.
Carreón-Torres E, Rendón-Sauer K, Monter-Garrido M, Toledo-Ibelles P, Gamboa R, Menjivar M, López-Marure R, Luc G, Fievet C, Cruz D, Vargas-Alarcón G, Pérez-Méndez O.
Carreón-Torres E, et al.
Clin Chim Acta. 2009 Mar;401(1-2):37-41. doi: 10.1016/j.cca.2008.11.003. Epub 2008 Nov 12.
Clin Chim Acta. 2009.
PMID: 19036342